|
1
|
Fares N and Peron JM: Epidemiology,
natural history, and risk factors of hepatocellular carcinoma. Rev
Prat. 63:216–217. 220–212. 2013.(In French).
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Karaman B, Battal B, Sari S and Verim S:
Hepatocellular carcinoma review: Current treatment, and
evidence-based medicine. World J Gastroenterol. 20:18059–18060.
2014.PubMed/NCBI
|
|
4
|
Uhm JE, Park JO, Lee J, Park YS, Park SH,
Yoo BC, Paik SW, Koh KC, Kang WK and Lim HY: A phase II study of
oxaliplatin in combination with doxorubicin as first-line systemic
chemotherapy in patients with inoperable hepatocellular carcinoma.
Cancer Chemother Pharmacol. 63:929–935. 2009. View Article : Google Scholar
|
|
5
|
Ge S and Huang D: Systemic therapies for
hepatocellular carcinoma. Drug Discov Ther. 9:352–362. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoon EL, Yeon JE, Lee HJ, Suh SJ, Lee SJ,
Kang SH, Kang K, Yoo YJ, Kim JH, Yim HJ, et al: Systemic cytotoxic
chemotherapy of patients with advanced hepatocellular carcinoma in
the era of sorafenib nonavailability. J Clin Gastroenterol.
48:e22–e29. 2014. View Article : Google Scholar
|
|
7
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al; SHARP Investigators Study Group. Sorafenib in advanced
hepatocellular carcinoma. N Engl J Med. 359:378–390. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han LT, Fang Y, Cao Y, Wu FH, Liu E, Mo GY
and Huang F: Triterpenoid saponin flaccidoside II from Anemone
flaccida triggers apoptosis of NF1-associated malignant peripheral
nerve sheath tumors via the MAPK-HO-1 pathway. Onco Targets Ther.
9:1969–1979. 2016.PubMed/NCBI
|
|
9
|
Xu J, Song Z, Guo Q and Li J: Synergistic
effect and molecular mechanisms of traditional Chinese medicine on
regulating tumor microenvironment and cancer cells. BioMed Res Int.
2016:14907382016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng M, Zhong LX, Zhan ZY, Huang ZH and
Xiong JP: Resveratrol treatment inhibits proliferation of and
induces apoptosis in human colon cancer cells. Med Sci Monit.
22:1101–1108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim MS, Bang JH, Lee J, Kim HW, Sung SH,
Han JS and Jeon WK: Salvia miltiorrhiza extract protects white
matter and the hippocampus from damage induced by chronic cerebral
hypoperfusion in rats. BMC Complement Altern Med. 15:4152015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang Y, Wang L, Zhang L, Wang T, Zhou Y,
Ding C, Yang R, Wang X and Yu L: Optimization of extraction and
antioxidant activity of polysaccharides from Salvia miltiorrhiza
Bunge residue. Int J Biol Macromol. 79:533–541. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou X, Cheung CM, Yang JM, Or PM, Lee WY
and Yeung JH: Danshen (Salvia miltiorrhiza) water extract inhibits
paracetamol-induced toxicity in primary rat hepatocytes via
reducing CYP2E1 activity and oxidative stress. J Pharm Pharmacol.
67:980–989. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang M, Wang P, Xu S, Xu W, Xu W, Chu K
and Lu J: Biological activities of salvianolic acid B from Salvia
miltiorrhiza on type 2 diabetes induced by high-fat diet and
streptozotocin. Pharm Biol. 53:1058–1065. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang ZS, Luo P, Dai SH, Liu ZB, Zheng XR
and Chen T: Salvianolic acid B induces apoptosis in human glioma
U87 cells through p38-mediated ROS generation. Cell Mol Neurobiol.
33:921–928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang Y, Ge PJ, Jiang L, Li FL and Zhu QY:
Modulation of growth and angiogenic potential of oral squamous
carcinoma cells in vitro using salvianolic acid B. BMC Complement
Altern Med. 11:542011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang QL, Wu Q, Tao YY, Liu CH and
El-Nezami H: Salvianolic acid B modulates the expression of
drug-metabolizing enzymes in HepG2 cells. Hepatobiliary Pancreat
Dis Int. 10:502–508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin C, Liu Z, Lu Y, Yao Y, Zhang Y, Ma Z,
Kuai M, Sun X, Sun S, Jing Y, et al: Cardioprotective effect of
salvianolic acid B on acute myocardial infarction by promoting
autophagy and neovascularization and inhibiting apoptosis. J Pharm
Pharmacol. 68:941–952. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang JY, Sun J, Huang MY, Wang YS, Hou MF,
Sun Y, He H, Krishna N, Chiu SJ, Lin S, et al: STIM1 overexpression
promotes colorectal cancer progression, cell motility and COX-2
expression. Oncogene. 34:4358–4367. 2015. View Article : Google Scholar :
|
|
20
|
Tagliamonte M, Petrizzo A, Tornesello ML,
Ciliberto G, Buonaguro FM and Buonaguro L: Combinatorial
immunotherapy strategies for hepatocellular carcinoma. Curr Opin
Immunol. 39:103–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee JH, Lee Y, Lee M, Heo MK, Song JS, Kim
KH, Lee H, Yi NJ, Lee KW, Suh KS, et al: A phase I/IIa study of
adjuvant immunotherapy with tumour antigen-pulsed dendritic cells
in patients with hepatocellular carcinoma. Br J Cancer.
113:1666–1676. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Babbitt SE, Sutherland MC, San Francisco
B, Mendez DL and Kranz RG: Mitochondrial cytochrome c biogenesis:
No longer an enigma. Trends Biochem Sci. 40:446–455. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kulikov AV, Shilov ES, Mufazalov IA,
Gogvadze V, Nedospasov SA and Zhivotovsky B: Cytochrome c: The
Achilles’ heel in apoptosis. Cell Mol Life Sci. 69:1787–1797. 2012.
View Article : Google Scholar
|
|
24
|
Hao Y, Xie T, Korotcov A, Zhou Y, Pang X,
Shan L, Ji H, Sridhar R, Wang P, Califano J, et al: Salvianolic
acid B inhibits growth of head and neck squamous cell carcinoma in
vitro and in vivo via cyclooxygenase-2 and apoptotic pathways. Int
J Cancer. 124:2200–2209. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao Y, Guo Y and Gu X: Salvianolic acid
B, a potential chemopreventive agent, for head and neck squamous
cell cancer. J Oncol. 2011:5345482011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ryter SW, Mizumura K and Choi AM: The
impact of autophagy on cell death modalities. Int J Cell Biol.
2014:5026762014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Levine B and Kroemer G: Autophagy in
aging, disease and death: The true identity of a cell death
impostor. Cell Death Differ. 16:1–2. 2009. View Article : Google Scholar :
|
|
29
|
Eskelinen EL and Saftig P: Autophagy: A
lysosomal degradation pathway with a central role in health and
disease. Biochim Biophys Acta. 1793:664–673. 2009. View Article : Google Scholar
|
|
30
|
Yang Z and Klionsky DJ: Eaten alive: A
history of macroautophagy. Nat Cell Biol. 12:814–822. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim N, Jeong S, Jing K, Shin S, Kim S, Heo
JY, Kweon GR, Park SK, Wu T, Park JI, et al: Docosahexaenoic acid
induces cell death in human non-small cell lung cancer cells by
repressing mTOR via AMPK activation and PI3K/Akt inhibition. BioMed
Res Int. 2015:2397642015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pan WR, Chen YL, Hsu HC and Chen WJ:
Antimicrobial peptide GW-H1-induced apoptosis of human gastric
cancer AGS cell line is enhanced by suppression of autophagy. Mol
Cell Biochem. 400:77–86. 2015. View Article : Google Scholar
|
|
34
|
Jing Z, Sui X, Yao J, Xie J, Jiang L, Zhou
Y, Pan H and Han W: SKF-96365 activates cytoprotective autophagy to
delay apoptosis in colorectal cancer cells through inhibition of
the calcium/CaMKIIγ/AKT-mediated pathway. Cancer Lett. 372:226–238.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hsin IL, Ou CC, Wu MF, Jan MS, Hsiao YM,
Lin CH and Ko JL: GMI, an immunomodulatory protein from Ganoderma
microsporum, potentiates cisplatin-induced apoptosis via autophagy
in lung cancer cells. Mol Pharm. 12:1534–1543. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen L, Meng Y, Sun Q, Zhang Z, Guo X,
Sheng X, Tai G, Cheng H and Zhou Y: Ginsenoside compound K
sensitizes human colon cancer cells to TRAIL-induced apoptosis via
autophagy-dependent and -independent DR5 upregulation. Cell Death
Dis. 7:e23342016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Young MM, Takahashi Y, Khan O, Park S,
Hori T, Yun J, Sharma AK, Amin S, Hu CD, Zhang J, et al:
Autophagosomal membrane serves as platform for intracellular
death-inducing signaling complex (iDISC)-mediated caspase-8
activation and apoptosis. J Biol Chem. 287:12455–12468. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang L, Wang K, Lei Y, Li Q, Nice EC and
Huang C: Redox signaling: Potential arbitrator of autophagy and
apoptosis in therapeutic response. Free Radic Biol Med. 89:452–465.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee JJ, Loh K and Yap YS: PI3K/Akt/mTOR
inhibitors in breast cancer. Cancer Biol Med. 12:342–354. 2015.
|
|
40
|
Janku F, Kaseb AO, Tsimberidou AM, Wolff
RA and Kurzrock R: Identification of novel therapeutic targets in
the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using
targeted next generation sequencing. Oncotarget. 5:3012–3022. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang F, Mao Y, You Q, Hua D and Cai D:
Piperlongumine induces apoptosis and autophagy in human lung cancer
cells through inhibition of PI3K/Akt/mTOR pathway. Int J
Immunopathol Pharmacol. 28:362–373. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Saito Y, Tanaka Y, Aita Y, Ishii KA, Ikeda
T, Isobe K, Kawakami Y, Shimano H, Hara H and Takekoshi K:
Sunitinib induces apoptosis in pheochromocytoma tumor cells by
inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of
Bcl-2 and BAD. Am J Physiol Endocrinol Metab. 302:E615–E625. 2012.
View Article : Google Scholar
|
